Strategic partnerships Beyond Cancer is actively engaging with prestigious research institutions (e.g., Stanford) and high-profile experts (SAB appointments). This presents an opportunity to align with their sponsored research programs, offer collaboration in preclinical studies, and provide related tools or services that support translational research.

Clinical stage signals The company is presenting preclinical data on UNO therapy at SITC and expanding its scientific leadership. Sales opportunities exist in providing specialized research services, contract development, or vendor support for untilled areas such as immune-oncology assay services or nitric oxide delivery platforms.

Small team dynamics With a lean headcount (2-10 employees) and notable hires in scientific and financial operations, Beyond Cancer may need scalable outsourced services, such as CRO/CMC support, grant management, or cloud-based collaboration tools that can grow with them.

Technology & tools Existing tech stack includes HubSpot, WordPress, and cloud/IT services, indicating openness to digital marketing, data analytics, and collaboration platforms. Opportunities exist to offer marketing automation optimization, analytics consulting, or secure R&D data management solutions.

Funding signals Reported revenue range ($1M–$10M) and ongoing high-profile collaborations suggest a growth trajectory with potential budget for strategic vendors in research, regulatory advisory, and IP/portfolio management services that support scale and partnerships.